Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript
2025-03-17 10:22:42 ET
Protalix BioTherapeutics, Inc. (PLX)
Q4 2024 Earnings Conference Call
March 17, 2025 8:30 AM ET
Company Participants
Mike Moyer - Investor Relations, LifeSci Advisors
Dror Bashan - President and Chief Executive Officer
Eyal Rubin - Senior Vice President and Chief Financial Officer
Conference Call Participants
Ram Selvaraju - H.C. Wainwright
John Vandermosten - Zach's SCR
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Fiscal Year 2024 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded.
I will now turn the conference over to your host, Mr. Mike Moyer of LifeSci Advisors, Investor Relations for Protalix. You may begin your conference....
Read the full article on Seeking Alpha
For further details see:
Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call TranscriptNASDAQ: PLX
PLX Trading
0.89% G/L:
$2.825 Last:
353,729 Volume:
$2.82 Open:



